283 related articles for article (PubMed ID: 31512284)
1. Morpholine as a privileged structure: A review on the medicinal chemistry and pharmacological activity of morpholine containing bioactive molecules.
Kourounakis AP; Xanthopoulos D; Tzara A
Med Res Rev; 2020 Mar; 40(2):709-752. PubMed ID: 31512284
[TBL] [Abstract][Full Text] [Related]
2. Morpholine as ubiquitous pharmacophore in medicinal chemistry: Deep insight into the structure-activity relationship (SAR).
Kumari A; Singh RK
Bioorg Chem; 2020 Mar; 96():103578. PubMed ID: 31978684
[TBL] [Abstract][Full Text] [Related]
3. Morpholine As a Scaffold in Medicinal Chemistry: An Update on Synthetic Strategies.
Tzara A; Xanthopoulos D; Kourounakis AP
ChemMedChem; 2020 Mar; 15(5):392-403. PubMed ID: 32017384
[TBL] [Abstract][Full Text] [Related]
4. Expanding Complex Morpholines Using Systematic Chemical Diversity.
Tang SA; Fults A; Boyd SR; Gattu N; Tran KA; Fan J; MacKenzie KR; Palzkill T; Young DW; Chamakuri S
Org Lett; 2024 May; 26(17):3493-3497. PubMed ID: 38506470
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.
Xu W; Gray DL; Glase SA; Barta NS
Bioorg Med Chem Lett; 2008 Oct; 18(20):5550-3. PubMed ID: 18805691
[TBL] [Abstract][Full Text] [Related]
6. De Novo Assembly of Highly Substituted Morpholines and Piperazines.
Patil P; Madhavachary R; Kurpiewska K; Kalinowska-Tłuścik J; Dömling A
Org Lett; 2017 Feb; 19(3):642-645. PubMed ID: 28102692
[TBL] [Abstract][Full Text] [Related]
7. Substituted 4-morpholine N-arylsulfonamides as γ-secretase inhibitors.
Zhao Z; Pissarnitski DA; Josien HB; Bara TA; Clader JW; Li H; McBriar MD; Rajagopalan M; Xu R; Terracina G; Hyde L; Song L; Zhang L; Parker EM; Osterman R; Buevich AV
Eur J Med Chem; 2016 Nov; 124():36-48. PubMed ID: 27560281
[TBL] [Abstract][Full Text] [Related]
8. Occurrence of Morpholine in Central Nervous System Drug Discovery.
Lenci E; Calugi L; Trabocchi A
ACS Chem Neurosci; 2021 Feb; 12(3):378-390. PubMed ID: 33459557
[TBL] [Abstract][Full Text] [Related]
9. Benzoxazine: A Privileged Scaffold in Medicinal Chemistry.
Tang Z; Tan Y; Chen H; Wan Y
Curr Med Chem; 2023; 30(4):372-389. PubMed ID: 35792127
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and structure-activity relationship of 4-substituted 2-(2-acetyloxyethyl)-8-(morpholine-4-sulfonyl)pyrrolo[3,4-c]quinoline-1,3-diones as potent caspase-3 inhibitors.
Kravchenko DV; Kuzovkova YA; Kysil VM; Tkachenko SE; Maliarchouk S; Okun IM; Balakin KV; Ivachtchenko AV
J Med Chem; 2005 Jun; 48(11):3680-3. PubMed ID: 15916416
[TBL] [Abstract][Full Text] [Related]
11. Revealing quinquennial anticancer journey of morpholine: A SAR based review.
Arshad F; Khan MF; Akhtar W; Alam MM; Nainwal LM; Kaushik SK; Akhter M; Parvez S; Hasan SM; Shaquiquzzaman M
Eur J Med Chem; 2019 Apr; 167():324-356. PubMed ID: 30776694
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic Activities of 5, 6-Diaryl/heteroaryl-3-substituted-1, 2, 4- triazines as a Privileged Scaffold in Drug Development.
Khatir ZZ; Irannejad H
Mini Rev Med Chem; 2021; 21(19):2874-2928. PubMed ID: 33719962
[TBL] [Abstract][Full Text] [Related]
13. 4-(1,3-Thiazol-2-yl)morpholine derivatives as inhibitors of phosphoinositide 3-kinase.
Alexander R; Balasundaram A; Batchelor M; Brookings D; Crépy K; Crabbe T; Deltent MF; Driessens F; Gill A; Harris S; Hutchinson G; Kulisa C; Merriman M; Mistry P; Parton T; Turner J; Whitcombe I; Wright S
Bioorg Med Chem Lett; 2008 Aug; 18(15):4316-20. PubMed ID: 18625552
[TBL] [Abstract][Full Text] [Related]
14. 1,3-Diazepine: A privileged scaffold in medicinal chemistry.
Malki Y; Martinez J; Masurier N
Med Res Rev; 2021 Jul; 41(4):2247-2315. PubMed ID: 33645848
[TBL] [Abstract][Full Text] [Related]
15. Developing potential agents against atherosclerosis: Design, synthesis and pharmacological evaluation of novel dual inhibitors of oxidative stress and Squalene Synthase activity.
Katselou MG; Matralis AN; Kourounakis AP
Eur J Med Chem; 2017 Sep; 138():748-760. PubMed ID: 28728107
[TBL] [Abstract][Full Text] [Related]
16. Chalcone: A Privileged Structure in Medicinal Chemistry.
Zhuang C; Zhang W; Sheng C; Zhang W; Xing C; Miao Z
Chem Rev; 2017 Jun; 117(12):7762-7810. PubMed ID: 28488435
[TBL] [Abstract][Full Text] [Related]
17. A review on antioxidant potential of bioactive heterocycle benzofuran: Natural and synthetic derivatives.
Chand K; Rajeshwari ; Hiremathad A; Singh M; Santos MA; Keri RS
Pharmacol Rep; 2017 Apr; 69(2):281-295. PubMed ID: 28171830
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of novel Schiff bases and azol-β-lactam derivatives starting from morpholine and thiomorpholine and investigation of their antitubercular, antiurease activity, acethylcolinesterase inhibition effect and antioxidant capacity.
Cebeci YU; Bayrak H; Şirin Y
Bioorg Chem; 2019 Jul; 88():102928. PubMed ID: 31005785
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of enantiomerically pure [
Edelmann MR; Hartung T; Trussardi R; Iding H; Galley G; Pflieger P; Norcross RD
J Labelled Comp Radiopharm; 2016 Dec; 59(14):635-639. PubMed ID: 27196363
[TBL] [Abstract][Full Text] [Related]
20. Medicinal chemistry of vicinal diaryl scaffold: A mini review.
Ramajayam R
Eur J Med Chem; 2019 Jan; 162():1-17. PubMed ID: 30396033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]